Technology
21 Oct 2026
OpenAI reportedly acquires Orchestra Bio for life‑science AI
OpenAI announced the purchase of the San Francisco startup Orchestra Bio, adding its AI‑driven drug‑development platform to its Rosalind life‑science suite.
Read more